Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gw Pharma ADR (NQ: GWPH )

153.44 USD +3.21 (+2.14%)
Streaming Delayed Price Updated: 9:56 AM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Gw Pharma ADR

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
24 25 Next >
Top CBD Companies to Capitalize, Should the Hoosier State Legalize Cannabidiol Oil
From PR Newswire
The Growth of Cannabis Legalization Across North America
FinancialBuzz.com News Commentary 
From PR Newswire
Pre-Market Technical Scan on Drug Makers Equities -- GW Pharma, Heron Therapeutics, Immune Pharma, and Johnson & Johnson
WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on GWPH, HRTX, IMNP, and JNJ which can be accessed for free by signing up to... 
From PR Newswire
GW Pharmaceuticals Receives Orphan Drug Designation from the European Medicines Agency (EMA) for Cannabidiol for the Treatment of Tuberous Sclerosis
GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary... 
From GlobeNewswire News Releases
India Globalization Advances Pre-Clinical Studies & CAM Products -- CFN Media
From NewMediaWire
India Globalization Advances Pre-Clinical Studies & CAM Products -- CFN Media
CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering India Globalization Capital... 
From GlobeNewswire News Releases
Medical and Recreational Cannabis Sales are on the Rise
FinancialBuzz.com News Commentary 
From PR Newswire
The Connection Between CBD Oil And Better Sleep
From PR Newswire
GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006
GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary... 
From GlobeNewswire News Releases
Data Shows Positive Projections for the Legal Cannabis Market in North America
FinancialBuzz.com News Commentary 
From PR Newswire
Cannabis Companies that Could Present Endless Opportunities for Investors
From PR Newswire
Cannabinoids Lead to Marijuana Biotech Boom
From PR Newswire
Medical Benefits in Legal Cannabis Products
FinancialBuzz.com News Commentary 
From PR Newswire
Investment Opportunities in Advanced Bioengineered Drug Delivery
From PR Newswire
GW Pharmaceuticals to Present at the Leerink Partners 7th Annual Global Healthcare Conference on 14 February
GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary... 
From GlobeNewswire News Releases
GW Pharmaceuticals plc Reports Fiscal First Quarter 2018 Financial Results and Operational Progress
GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary... 
From GlobeNewswire News Releases
GW Pharmaceuticals Announces the European Medicines Agency (EMA) Accepts Epidiolex® (cannabidiol) Marketing Authorization Application (MAA) for Review
MAA seeking regulatory approval of Epidiolex for seizures associated with Lennox-Gastaut syndrome and Dravet syndrome 
From GlobeNewswire News Releases
The Legal Cannabis Market is Projected to Grow Across North America
FinancialBuzz.com News Commentary 
From PR Newswire
GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 5 February, 2018
GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid... 
From GlobeNewswire News Releases
Fast-Growing Cannabis Industry Drives Biotech Research, Innovative Medical Therapy Development
From PR Newswire
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex® (cannabidiol) Study in The Lancet
GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary... 
From GlobeNewswire News Releases
How the Marijuana Industry Will Actually Prevail Over Jeff Sessions
From PR Newswire
GB Sciences, Inc. (OTCQB: GBLX), a Speculative Buy Ahead of Shareholder Meeting
Tags healthcare/pharmaceuticals h:worldnews culture/society/lifestyle
From EIN Presswire
Arizona Law May Protect Medical-marijuana Users From Feds' New Stance
FN Media Group Presents USA News Group News Commentary 
From PR Newswire
Legalization Boost Sales in Cannabis Products
FinancialBuzz.com News Commentary 
From PR Newswire
Cannabis Companies That are Primed for a big Year
FN Media Group Presents Microcapspeculators.com News Commentary 
From PR Newswire
Legal Cannabis Sales Expected to Grow and Benefit North America Economy
FinancialBuzz.com News Commentary 
From PR Newswire
Legal Cannabis Projections Indicate Strong Growth
FinancialBuzz.com News Commentary 
From PR Newswire
GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome
GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid... 
From GlobeNewswire News Releases
GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome
GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid... 
From GlobeNewswire News Releases
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.